Mandate

Vinge has advised Great Security and Garda Group in connection with the acquisition of Comdate Norrlarm

Vinge has advised Great Security, one of Sweden’s largest security companies, in connection with the acquisition of Comdate Norrlarm, the largest independent alarm and security company in northern Sweden. The acquisition strengthens Great Security’s presence in the region and provides direct access to this geographical market.

Comdate Norrlarm is a leading operator in the alarm and security industry and offers advanced security solutions in the areas of burglar alarms, fire alarms, camera surveillance and access control systems.

Great Security is part of Garda Group, one of the largest providers of physical security in Northern Europe. Garda Group consists of security companies in Sweden, Denmark, Norway, Finland, and Germany. Together, the companies have approximately 2,100 employees and an annual turnover of over 5 billion SEK.

Vinge’s team consisted of among other Carl Sander, Linus Adolfsson and Sara Hammond (M&A), Simon Söderholm and Gulestan Ali (Employment), Carla Håkansson, Elis Allmark and Nicklas Thorgerzon (Commercial Contracts, IT and GDPR), Johan Gavelin and Siri Blomberg (IP), Kristoffer Sällfors (Public procurement), Dagne Sabockis and Martin Hammarskiöld (FDI) and Cecilia Loctander (Transaction Support).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026